By failing to settle like Purdue Pharma, JNJ is taking a risky gamble that could open itself up to many more state court battles and penalties.
Executive slams short-seller Andrew Left's report.
Shortseller Andrew Left says Jumia's post IPO stock jump is built on fraud.
Aetna's additive effects on CVS's earnings might be front and center, but it isn't fully actualized just yet.
Tesla's CEO is encountering an experienced jurist on Thursday.
Facebook held its annual shareholding meeting today and media reports confirm it's keeping all current members including billionaire Peter Thiel on the board.
European Commission considers expanding the role of national competition authorities in the EU's 28 member countries, White & Case Case LLP partner shares his views on areas of possible reform.
This week's arrest of hedge fund manager Murray Huberfeld for an alleged kickback scheme with New York City's correction officers union didn't surprise one private eye.
Goldman Sachs is being investigated by U.S. law enforcement officials for not alerting authorities about a suspicious transaction involving a Malaysian investment fund, according to reports.
Shares of E*Trade getting hit Friday in tandem with the broader selloff in financials in response to the weak May jobs report.